EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro

Onyedika Emmanuel Okpala iD, Johana Rondevaldova iD, Hayford Osei-Owusu, Tomas Kudera, Tersia Kokoskova, Ladislav Kokoska iD

Molecules · 2024

DOI: 10.3390/molecules29153665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Onyedika Emmanuel Okpala und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Crop Sciences and Agroforestry, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, Suchdol, 165 0…. Hauptthemen laut MEDLINE: Oxacillin, Celecoxib, Microbial Sensitivity Tests, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Internal Grant Agency of the Faculty of Tropical AgriSciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Musculoskeletal infections (MIs) are among the most difficult-to-treat staphylococcal diseases due to antibiotic resistance. This has encouraged the development of innovative strategies, such as combination therapy, to combat MI. The aim of this study was to investigate the in vitro antistaphylococcal activity of anti-inflammatory drugs and the combined antimicrobial effect of celecoxib and oxacillin. The minimum inhibitory concentrations (MICs) of 17 anti-inflammatory drugs against standard strains and clinical isolates of S. aureus, including methicillin-resistant strains (MRSAs), were determined using the broth microdilution method. The fractional inhibitory concentration indices (FICIs) were evaluated using checkerboard assays. Celecoxib produced the most potent antistaphylococcal effect against all tested strains (MICs ranging from 32 to 64 mg/L), followed by that of diacerein against MRSA3 and MRSA ATCC 33592 (MIC 64 mg/L). Several synergistic effects were observed against the tested S. aureus strains, including MRSA (FICI ranging from 0.087 to 0.471). The strongest synergistic interaction (FICI 0.087) was against MRSA ATCC 33592 at a celecoxib concentration of 2 mg/L, with a 19-fold oxacillin MIC reduction (from 512 to 26.888 mg/L). This is the first report on the combined antistaphylococcal effect of celecoxib and oxacillin. These findings suggest celecoxib and its combination with oxacillin as perspective agents for research focused on the development of novel therapies for MI caused by S. aureus. This study further indicates that celecoxib could resensitize certain MRSA strains, in some cases, to be susceptible to β-lactams (e.g., oxacillin) that were not previously tested. It is essential to mention that the in vitro concentrations of anti-inflammatory drugs are higher than those typically obtained in patients. Therefore, an alternative option for its administration could be the use of a drug delivery system for the controlled slow release from an implant at the infection site.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxacillinCelecoxibMicrobial Sensitivity TestsMethicillin-Resistant Staphylococcus aureusDrug SynergismAnti-Bacterial AgentsStaphylococcus aureusAnti-Inflammatory AgentsHumansStaphylococcal Infections

Stichwörter der Autor:innen

antibacterial activityantistaphylococcal synergistic effectmethicillin-resistant S. aureusmusculoskeletal infectionsnon-steroidal anti-inflammatory drugs

Substanzen

OxacillinCelecoxibAnti-Bacterial AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Crop Sciences and Agroforestry, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, Suchdol, 165 00 Prague, Czech Republic.
  • Drift-Food Research Centre, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, Kamycka 129, Suchdol, 165 00 Prague, Czech Republic.
  • Department of Animal Science and Food Processing, Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague, Kamycka 129, Suchdol, 165 00 Prague, Czech Republic.

ORCID-Profile: Onyedika Emmanuel Okpala, Johana Rondevaldova, Ladislav Kokoska

Förderung

  • Internal Grant Agency of the Faculty of Tropical AgriSciences

Zitieren

APA

Okpala, O. E., Rondevaldova, J., Osei-Owusu, H., Kudera, T., Kokoskova, T., & Kokoska, L. (2024). Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro. Molecules. https://doi.org/10.3390/molecules29153665

Vancouver

Okpala OE, Rondevaldova J, Osei-Owusu H, Kudera T, Kokoskova T, Kokoska L. Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro. Molecules. 2024. doi:10.3390/molecules29153665

BibTeX
@article{Okpala2024,
  author = {Okpala, Onyedika Emmanuel and Rondevaldova, Johana and Osei-Owusu, Hayford and Kudera, Tomas and Kokoskova, Tersia and Kokoska, Ladislav},
  title = {Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29153665}
}
Kostenlos starten →